The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Mar. 20, 2008
Applicants:
Zhihui Qiu, Bridgewater, NJ (US);
Wing-kee Philip Cho, Princeton, NJ (US);
NA Zhao, Belle Mead, NJ (US);
Victor Ming-she Wong, Berkeley Heights, NJ (US);
Inventors:
Zhihui Qiu, Bridgewater, NJ (US);
Wing-Kee Philip Cho, Princeton, NJ (US);
Na Zhao, Belle Mead, NJ (US);
Victor Ming-she Wong, Berkeley Heights, NJ (US);
Assignee:
Opko Health, Inc., Miami, FL (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 31/44 (2006.01); A01N 43/42 (2006.01); C07D 491/00 (2006.01); C07D 495/00 (2006.01); C07D 491/10 (2006.01); C07D 497/20 (2006.01); C07D 215/00 (2006.01); C07D 219/00 (2006.01);
U.S. Cl.
CPC ...
Abstract
Pharmaceutical formulations containing a salt of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, which are suitable for forming into a tablet dosage form, as well as tablet dosage forms are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.